Jets head coach Aaron Glenn looks on during the loss to the Bills on Sept. 14, 2025. Corey Sipkin for the NY POST The Jets got run over by the Bills on Sunday, losing 30-10 to drop to 0-2 for the ...
Bryce Young had a pretty bad Week 1 for the Carolina Panthers. Before that week, Bleacher Report noted that his lack of support was Carolina's biggest problem. That reared its ugly head against the ...
Sept 11 (Reuters) - Chinese e-commerce leader Alibaba (9988.HK), opens new tab said on Thursday it plans to raise $3.2 billion through the sale of a zero-coupon convertible bond to fund international ...
Investing.com-- Alibaba Group (HK:9988) on Thursday said it plans to raise about $3.2 billion through a zero-coupon convertible bond offering, with most of the proceeds earmarked for strengthening its ...
Nearly 80% of proceeds are set aside for building new data centers, upgrading technology and improving cloud services to handle the rising demand for artificial intelligence computing. The rest will ...
Alibaba is looking to raise $3.2 billion through the sale of zero-coupon convertible bonds. As reported by Reuters, the funding will be used for Alibaba's international expansion and to "strengthen" ...
(Bloomberg) --Alibaba Group Holding Ltd. is leading a fundraising spree among Chinese tech giants, driven by soaring capital demands amid intensifying competition in artificial intelligence. The ...
The e-commerce and technology giant said nearly 80% of the proceeds will go toward expanding data centers, upgrading technology and improving services. The senior note, set to mature on Sept. 15, 2032 ...
Dell impresses with the Plus 16 2-in-1 convertible laptop, starting with the Intel Core Ultra 7 256V "Lunar Lake" CPU, 16-inch 1600p @ 90Hz Mini-LED, and a fantastic keyboard. Oh, and it folds into a ...
ICVT follows the convertible bond market, but it seems it cannot benefit from its main advantages. It does not optimize convexity or asset selection, two elements, in my opinion, essential for this ...
Santhera Pharmaceuticals (SIX: SANN) is a Swiss specialty pharmaceutical company focused on the development and commercialization of innovative medicines for rare neuromuscular diseases with high ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback